| 1 | [SID24814601] | Active | IC50 | 1.09 | Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588400, Type: confirmatory] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 1.09 [uM] | | BioAssay | Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588400 | | BioAssay type | confirmatory | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 2 | [SID24814601] | Active | IC50 | 1.09 | Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588400, Type: confirmatory] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 1.09 [uM] | | BioAssay | Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588400 | | BioAssay type | confirmatory | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 3 | [SID89650255] | Active | IC50 | 1.454 | Late stage results from the probe development effort to identify MCL1-BIM inhibitors: Fluorescence polarization-based biochemical dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide [AID2791, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 89650255 | | CID | 16194416 | | Outcome | Active | | IC50 | 1.454 [uM] | | BioAssay | Late stage results from the probe development effort to identify MCL1-BIM inhibitors: Fluorescence polarization-based biochemical dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide | | AID | 2791 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 4 | [SID89650255] | Active | IC50 | 1.454 | Late stage results from the probe development effort to identify MCL1-BIM inhibitors: Fluorescence polarization-based biochemical dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide [AID2791, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 89650255 | | CID | 16194416 | | Outcome | Active | | IC50 | 1.454 [uM] | | BioAssay | Late stage results from the probe development effort to identify MCL1-BIM inhibitors: Fluorescence polarization-based biochemical dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide | | AID | 2791 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 5 | [SID89650255] | Active | IC50 | 1.454 | Late stage results from the probe development effort to identify MCL1-BIM inhibitors: Fluorescence polarization-based biochemical dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide [AID2791, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 89650255 | | CID | 16194416 | | Outcome | Active | | IC50 | 1.454 [uM] | | BioAssay | Late stage results from the probe development effort to identify MCL1-BIM inhibitors: Fluorescence polarization-based biochemical dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide | | AID | 2791 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 6 | [SID24814601] | Active | IC50 | 2.27 | Fluorescent assay for identification of compounds that inhibit VHR1 [AID1878, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 2.27 [uM] | | BioAssay | Fluorescent assay for identification of compounds that inhibit VHR1 | | AID | 1878 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 7 | [SID24814601] | Active | IC50 | 2.27 | Fluorescent assay for identification of compounds that inhibit VHR1 [AID1878, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 2.27 [uM] | | BioAssay | Fluorescent assay for identification of compounds that inhibit VHR1 | | AID | 1878 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 8 | [SID24814601] | Active | Potency | 2.6679 | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation [AID540279, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 2.6679 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation | | AID | 540279 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 9 | [SID24814601] | Active | Potency | 2.6679 | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation [AID540279, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 2.6679 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1: Hit Validation | | AID | 540279 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 10 | [SID24814601] | Active | IC50 | 2.73 | Dose response confirmation of the uHTS fluorescent assay for identification of inhibitors of ATG4B. [AID504756, Type: confirmatory] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 2.73 [uM] | | BioAssay | Dose response confirmation of the uHTS fluorescent assay for identification of inhibitors of ATG4B. | | AID | 504756 | | BioAssay type | confirmatory | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 11 | [SID24814601] | Active | IC50 | 2.85 | Dose Response Confirmation for Small Molecule Inhibitors of Epstein-Barr Virus [AID1419, Type: confirmatory] | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 2.85 [uM] | | BioAssay | Dose Response Confirmation for Small Molecule Inhibitors of Epstein-Barr Virus | | AID | 1419 | | BioAssay type | confirmatory | | Target | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] | | PubMed | | | Data Table |  |
|
| 12 | [SID24814601] | Active | IC50 | 3.22 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 3.22 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 13 | [SID24814601] | Active | IC50 | 3.22 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 3.22 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 14 | [SID24814601] | Active | IC50 | 3.22 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 3.22 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 15 | [SID24814601] | Active | Potency | 3.6588 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 3.6588 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 16 | [SID24814601] | Active | IC50 | 4.935 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2217, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 4.935 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2217 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 17 | [SID24814601] | Active | IC50 | 4.935 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2217, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 4.935 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2217 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 18 | [SID24814601] | Active | IC50 | 4.935 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2217, Type: confirmatory] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 4.935 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2217 | | BioAssay type | confirmatory | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 19 | [SID24814601] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 20 | [SID24814601] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 21 | [SID24814601] | Active | IC50 | 6.65 | uHTS absorbance assay for the identification of compounds that inhibit VHR1. [AID1654, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 6.65 [uM] | | BioAssay | uHTS absorbance assay for the identification of compounds that inhibit VHR1. | | AID | 1654 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 22 | [SID24814601] | Active | IC50 | 6.65 | uHTS absorbance assay for the identification of compounds that inhibit VHR1. [AID1654, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 6.65 [uM] | | BioAssay | uHTS absorbance assay for the identification of compounds that inhibit VHR1. | | AID | 1654 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 23 | [SID24814601] | Active | Potency | 7.0795 | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks [AID504841, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks | | AID | 504841 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 24 | [SID24814601] | Active | IC50 | 7.793 | Fluorescence-based biochemical high throughput dose response assay for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3). [AID2173, Type: confirmatory] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 7.793 [uM] | | BioAssay | Fluorescence-based biochemical high throughput dose response assay for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3). | | AID | 2173 | | BioAssay type | confirmatory | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 25 | [SID24814601] | Active | Potency | 8.9125 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 26 | [SID24814601] | Active | Potency | 8.9125 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 27 | [SID24814601] | Active | IC50 | 9.04 | MKP-3 in vitro HTS assay [AID425, Type: confirmatory] | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 9.04 [uM] | | BioAssay | MKP-3 in vitro HTS assay | | AID | 425 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] | | PubMed | | | Data Table |  |
|
| 28 | [SID24814601] | Active | IC50 | 9.04 | MKP-3 in vitro HTS assay [AID425, Type: confirmatory] | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 9.04 [uM] | | BioAssay | MKP-3 in vitro HTS assay | | AID | 425 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 6 [Rattus norvegicus] [gi:16758752] | | PubMed | | | Data Table |  |
|
| 29 | [SID24814601] | Active | Potency | 10 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 30 | [SID24814601] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 31 | [SID24814601] | Active | IC50 | 14.1 | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 14.1 [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 32 | [SID24814601] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 33 | [SID24814601] | Active | Potency | 14.1254 | Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID489007, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 489007 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 34 | [SID24814601] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 35 | [SID24814601] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 36 | [SID24814601] | Active | IC50 | 19.2803 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 19.2803 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 37 | [SID24814601] | Active | IC50 | 19.2803 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 19.2803 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 38 | [SID24814601] | Active | IC50 | 19.2803 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 19.2803 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 39 | [SID24814601] | Active | Potency | 22.3872 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 40 | [SID24814601] | Active | Potency | 22.3872 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 41 | [SID24814601] | Active | IC50 | 33.244 | Anti-Viral Drugs Against Arbovirus Infections, a Confirmatory Screen [AID1250, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | 33.244 [uM] | | BioAssay | Anti-Viral Drugs Against Arbovirus Infections, a Confirmatory Screen | | AID | 1250 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID24814601] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 43 | [SID24814601] | Active | | | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress [AID2732, Type: screening] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress | | AID | 2732 | | BioAssay type | screening | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 44 | [SID24814601] | Active | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 45 | [SID24814601] | Active | | | uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors [AID1085, Type: screening] | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors | | AID | 1085 | | BioAssay type | screening | | Target | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] | | PubMed | | | Data Table |  |
|
| 46 | [SID24814601] | Active | | | uHTS for 14-3-3/Bad interaction inhibitors [AID781, Type: screening] | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [Bos taurus [gi:27807367] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | uHTS for 14-3-3/Bad interaction inhibitors | | AID | 781 | | BioAssay type | screening | | Target | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [Bos taurus [gi:27807367] | | PubMed | | | Data Table |  |
|
| 47 | [SID24814601] | Active | | | uHTS identification of inhibitors of NadD in a Colorimetric assay [AID602399, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of NadD in a Colorimetric assay | | AID | 602399 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 48 | [SID24814601] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 49 | [SID24814601] | Active | IC50 | | uHTS HTRF assay for identification of inhibitors of SUMOylation [AID2006, Type: confirmatory] | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS HTRF assay for identification of inhibitors of SUMOylation | | AID | 2006 | | BioAssay type | confirmatory | | Target | SUMO-conjugating enzyme UBC9 [Homo sapiens] [gi:4507785] | | PubMed | | | Data Table |  |
|
| 50 | [SID24814601] | Active | | | Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen [AID1251, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24814601 | | CID | 16194416 | | Outcome | Active | | BioAssay | Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen | | AID | 1251 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|